Loading…

Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor

The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth. In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin. These women comprised 4 groups: gro...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2004-06, Vol.190 (6), p.1582-1587
Main Authors: Stevens, Amy O, Chauhan, Suneet P, Magann, Everett F, Martin, Rick W, Bofill, James A, Cushman, Julie L, Morrison, John C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253
cites cdi_FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253
container_end_page 1587
container_issue 6
container_start_page 1582
container_title American journal of obstetrics and gynecology
container_volume 190
creator Stevens, Amy O
Chauhan, Suneet P
Magann, Everett F
Martin, Rick W
Bofill, James A
Cushman, Julie L
Morrison, John C
description The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth. In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin. These women comprised 4 groups: group A (n = 23 women; +bacterial vaginosis/+fetal fibronectin); group B (n = 31 women; −bacterial vaginosis/+fetal fibronectin); group C (n = 47 women; +bacterial vaginosis/−fetal fibronectin); and group D (n = 84 women; −bacterial vaginosis/−fetal fibronectin). The time interval from gestational age at testing until delivery was significantly shorter for groups A and B versus groups C and D ( P ≤ .05 and P < .001, respectively). Similarly, delivery at
doi_str_mv 10.1016/j.ajog.2004.03.059
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66756284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937804003254</els_id><sourcerecordid>66756284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi1ERZe2L8AB-cQtYewkjiNxQVULSJW40LM1tietV0m82NlW5enxsiu4cbE98vf_0nyMvRNQCxDq47bGbXyoJUBbQ1NDN7xiGwFDXymt9Gu2AQBZDU2vz9nbnLeHUQ7yDTsXndRt34oN-3VLK058DDbFhdwaFo6L5xbdSimUnyd8CEvMIXNMxDHn6AKu5PlzWB_5LlHhZm5DKlMJP8eZyvkY_-D5Zd6tccY1OD7G9Bef0MZ0yc5GnDJdne4Ldn978-P6a3X3_cu36893lZOqXytqPY221VZ54VvwqhscikZplMr2arTljQo0AGq0HXgHYnTYW63IO9k1F-zDsXeX4s895dXMITuaJlwo7rNRqu9U8VFAeQRdijknGs0uhRnTixFgDsbN1hyMm4NxA40pxkvo_al9b2fy_yInxQX4dASo7PgUKJnsAi2OfEhFuPEx_K__N6WmlSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66756284</pqid></control><display><type>article</type><title>Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor</title><source>ScienceDirect Freedom Collection</source><creator>Stevens, Amy O ; Chauhan, Suneet P ; Magann, Everett F ; Martin, Rick W ; Bofill, James A ; Cushman, Julie L ; Morrison, John C</creator><creatorcontrib>Stevens, Amy O ; Chauhan, Suneet P ; Magann, Everett F ; Martin, Rick W ; Bofill, James A ; Cushman, Julie L ; Morrison, John C</creatorcontrib><description>The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth. In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin. These women comprised 4 groups: group A (n = 23 women; +bacterial vaginosis/+fetal fibronectin); group B (n = 31 women; −bacterial vaginosis/+fetal fibronectin); group C (n = 47 women; +bacterial vaginosis/−fetal fibronectin); and group D (n = 84 women; −bacterial vaginosis/−fetal fibronectin). The time interval from gestational age at testing until delivery was significantly shorter for groups A and B versus groups C and D ( P ≤ .05 and P &lt; .001, respectively). Similarly, delivery at &lt;32 weeks of gestation was increased in group B (26%) compared with groups A (9%), C (2%), and D (5%; P &lt; .009; odds ratio, 165.90; 95% CI, 30.02, 916.08). Women who are symptomatic for preterm labor should be considered for fetal fibronectin and bacterial vaginosis testing.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2004.03.059</identifier><identifier>PMID: 15284741</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adult ; Bacterial vaginosis ; Biomarkers - analysis ; Cohort Studies ; Female ; Fetal fibronectin ; Fibronectins ; Gestational Age ; Glycoproteins - analysis ; Glycoproteins - metabolism ; Humans ; Incidence ; Infant, Newborn ; Infant, Premature ; Obstetric Labor, Premature - epidemiology ; Pregnancy ; Pregnancy Complications, Infectious - epidemiology ; Pregnancy Outcome ; Preterm birth ; Probability ; Prospective Studies ; Risk Assessment ; Sensitivity and Specificity ; Severity of Illness Index ; Statistics, Nonparametric ; Vaginosis, Bacterial - diagnosis ; Vaginosis, Bacterial - epidemiology</subject><ispartof>American journal of obstetrics and gynecology, 2004-06, Vol.190 (6), p.1582-1587</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253</citedby><cites>FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15284741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stevens, Amy O</creatorcontrib><creatorcontrib>Chauhan, Suneet P</creatorcontrib><creatorcontrib>Magann, Everett F</creatorcontrib><creatorcontrib>Martin, Rick W</creatorcontrib><creatorcontrib>Bofill, James A</creatorcontrib><creatorcontrib>Cushman, Julie L</creatorcontrib><creatorcontrib>Morrison, John C</creatorcontrib><title>Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth. In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin. These women comprised 4 groups: group A (n = 23 women; +bacterial vaginosis/+fetal fibronectin); group B (n = 31 women; −bacterial vaginosis/+fetal fibronectin); group C (n = 47 women; +bacterial vaginosis/−fetal fibronectin); and group D (n = 84 women; −bacterial vaginosis/−fetal fibronectin). The time interval from gestational age at testing until delivery was significantly shorter for groups A and B versus groups C and D ( P ≤ .05 and P &lt; .001, respectively). Similarly, delivery at &lt;32 weeks of gestation was increased in group B (26%) compared with groups A (9%), C (2%), and D (5%; P &lt; .009; odds ratio, 165.90; 95% CI, 30.02, 916.08). Women who are symptomatic for preterm labor should be considered for fetal fibronectin and bacterial vaginosis testing.</description><subject>Adult</subject><subject>Bacterial vaginosis</subject><subject>Biomarkers - analysis</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Fetal fibronectin</subject><subject>Fibronectins</subject><subject>Gestational Age</subject><subject>Glycoproteins - analysis</subject><subject>Glycoproteins - metabolism</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Obstetric Labor, Premature - epidemiology</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - epidemiology</subject><subject>Pregnancy Outcome</subject><subject>Preterm birth</subject><subject>Probability</subject><subject>Prospective Studies</subject><subject>Risk Assessment</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Statistics, Nonparametric</subject><subject>Vaginosis, Bacterial - diagnosis</subject><subject>Vaginosis, Bacterial - epidemiology</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi1ERZe2L8AB-cQtYewkjiNxQVULSJW40LM1tietV0m82NlW5enxsiu4cbE98vf_0nyMvRNQCxDq47bGbXyoJUBbQ1NDN7xiGwFDXymt9Gu2AQBZDU2vz9nbnLeHUQ7yDTsXndRt34oN-3VLK058DDbFhdwaFo6L5xbdSimUnyd8CEvMIXNMxDHn6AKu5PlzWB_5LlHhZm5DKlMJP8eZyvkY_-D5Zd6tccY1OD7G9Bef0MZ0yc5GnDJdne4Ldn978-P6a3X3_cu36893lZOqXytqPY221VZ54VvwqhscikZplMr2arTljQo0AGq0HXgHYnTYW63IO9k1F-zDsXeX4s895dXMITuaJlwo7rNRqu9U8VFAeQRdijknGs0uhRnTixFgDsbN1hyMm4NxA40pxkvo_al9b2fy_yInxQX4dASo7PgUKJnsAi2OfEhFuPEx_K__N6WmlSg</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Stevens, Amy O</creator><creator>Chauhan, Suneet P</creator><creator>Magann, Everett F</creator><creator>Martin, Rick W</creator><creator>Bofill, James A</creator><creator>Cushman, Julie L</creator><creator>Morrison, John C</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200406</creationdate><title>Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor</title><author>Stevens, Amy O ; Chauhan, Suneet P ; Magann, Everett F ; Martin, Rick W ; Bofill, James A ; Cushman, Julie L ; Morrison, John C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Bacterial vaginosis</topic><topic>Biomarkers - analysis</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Fetal fibronectin</topic><topic>Fibronectins</topic><topic>Gestational Age</topic><topic>Glycoproteins - analysis</topic><topic>Glycoproteins - metabolism</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Obstetric Labor, Premature - epidemiology</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - epidemiology</topic><topic>Pregnancy Outcome</topic><topic>Preterm birth</topic><topic>Probability</topic><topic>Prospective Studies</topic><topic>Risk Assessment</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Statistics, Nonparametric</topic><topic>Vaginosis, Bacterial - diagnosis</topic><topic>Vaginosis, Bacterial - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stevens, Amy O</creatorcontrib><creatorcontrib>Chauhan, Suneet P</creatorcontrib><creatorcontrib>Magann, Everett F</creatorcontrib><creatorcontrib>Martin, Rick W</creatorcontrib><creatorcontrib>Bofill, James A</creatorcontrib><creatorcontrib>Cushman, Julie L</creatorcontrib><creatorcontrib>Morrison, John C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stevens, Amy O</au><au>Chauhan, Suneet P</au><au>Magann, Everett F</au><au>Martin, Rick W</au><au>Bofill, James A</au><au>Cushman, Julie L</au><au>Morrison, John C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2004-06</date><risdate>2004</risdate><volume>190</volume><issue>6</issue><spage>1582</spage><epage>1587</epage><pages>1582-1587</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth. In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin. These women comprised 4 groups: group A (n = 23 women; +bacterial vaginosis/+fetal fibronectin); group B (n = 31 women; −bacterial vaginosis/+fetal fibronectin); group C (n = 47 women; +bacterial vaginosis/−fetal fibronectin); and group D (n = 84 women; −bacterial vaginosis/−fetal fibronectin). The time interval from gestational age at testing until delivery was significantly shorter for groups A and B versus groups C and D ( P ≤ .05 and P &lt; .001, respectively). Similarly, delivery at &lt;32 weeks of gestation was increased in group B (26%) compared with groups A (9%), C (2%), and D (5%; P &lt; .009; odds ratio, 165.90; 95% CI, 30.02, 916.08). Women who are symptomatic for preterm labor should be considered for fetal fibronectin and bacterial vaginosis testing.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>15284741</pmid><doi>10.1016/j.ajog.2004.03.059</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2004-06, Vol.190 (6), p.1582-1587
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_66756284
source ScienceDirect Freedom Collection
subjects Adult
Bacterial vaginosis
Biomarkers - analysis
Cohort Studies
Female
Fetal fibronectin
Fibronectins
Gestational Age
Glycoproteins - analysis
Glycoproteins - metabolism
Humans
Incidence
Infant, Newborn
Infant, Premature
Obstetric Labor, Premature - epidemiology
Pregnancy
Pregnancy Complications, Infectious - epidemiology
Pregnancy Outcome
Preterm birth
Probability
Prospective Studies
Risk Assessment
Sensitivity and Specificity
Severity of Illness Index
Statistics, Nonparametric
Vaginosis, Bacterial - diagnosis
Vaginosis, Bacterial - epidemiology
title Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A57%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20fibronectin%20and%20bacterial%20vaginosis%20are%20associated%20with%20preterm%20birth%20in%20women%20who%20are%20symptomatic%20for%20preterm%20labor&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Stevens,%20Amy%20O&rft.date=2004-06&rft.volume=190&rft.issue=6&rft.spage=1582&rft.epage=1587&rft.pages=1582-1587&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2004.03.059&rft_dat=%3Cproquest_cross%3E66756284%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c267t-e4defb48b6d1d40d659ca1368a26b76fb136a60800a8ab50dc01fca7b86edc253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66756284&rft_id=info:pmid/15284741&rfr_iscdi=true